Aurora Cannabis | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Aurora Cannabis | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Aurora Cannabis | 6-K: Aurora Cannabis Inc. Announces Filing and Mailing of Management Information Circular in Connection with Upcoming Annual General and Special Meeting of Shareholders
Aurora Cannabis | 6-K: Report of foreign private issuer (related to financial reporting)
Aurora Cannabis | 6-K: Report of foreign private issuer (related to financial reporting)
Aurora Cannabis | 6-K: Report of foreign private issuer (related to financial reporting)
Aurora Cannabis | 40-F: Annual reports filed by certain Canadian issuers
Aurora Cannabis | 6-K: Report of foreign private issuer (related to financial reporting)
Aurora Cannabis | 6-K: Notice of Meeting and Record Date
Aurora Cannabis | 6-K: Aurora Cannabis Announces Appointment of New Director
Aurora Cannabis | 6-K: Aurora Marks First Shipment of Medical Cannabis to the New Zealand Market
Aurora Cannabis | 6-K: Notice of Change of Auditor
Aurora Cannabis | 6-K: Aurora Completes Final Repayment of Convertible Senior Notes Representing ~$465 Million in Total Repayments Since 2021; Cannabis Operations Are Now Debt Free
Aurora Cannabis | 6-K: Aurora Cannabis Announces CFO Transition and Completion of Previously Announced Share Consolidation
Aurora Cannabis | 6-K: Material Change Report
Aurora Cannabis | 6-K: Report of foreign private issuer (related to financial reporting)
Aurora Cannabis | 6-K: Report of foreign private issuer (related to financial reporting)
Aurora Cannabis | 6-K: Aurora Cannabis Acquires MedReleaf Australia
Aurora Cannabis | 6-K: Report of foreign private issuer (related to financial reporting)
Aurora Cannabis | 6-K: Report of foreign private issuer (related to financial reporting)
No Data